1. 93 Targeting sirt2 rescues the metabolic fitness and effector functions of tumor-reactive T cells within the metabolically restricted tumor microenvironment. (9th November 2020) Authors: Hamaidi, Imene; Zhang, Lin; Kim, Nayoung; Wang, Min-Hsuan; Iclozan, Cristina; Fang, Bin; Liu, Min; Koomen, John; Berglund, Anders; Yoder, Sean; Yao, Jiqiang; Engelman, Robert; Creelan, Ben; Conejo-Garcia, Jose; Antonia, Scott; Mule, James; Kim, Sungjune Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial. Issue 10357 (24th September 2022) Authors: Kim, Sungjune; Wuthrick, Evan; Blakaj, Dukagjin; Eroglu, Zeynep; Verschraegen, Claire; Thapa, Ram; Mills, Matthew; Dibs, Khaled; Liveringhouse, Casey; Russell, Jeffery; Caudell, Jimmy J; Tarhini, Ahmad; Markowitz, Joseph; Kendra, Kari; Wu, Richard; Chen, Dung-Tsa; Berglund, Anders; Michael, Laure... Journal: Lancet Issue: Volume 400:Issue 10357(2022) Page Start: 1008 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗